Eckhardt Sue Gail 4
4 · Syros Pharmaceuticals, Inc. · Filed Sep 9, 2020
Insider Transaction Report
Form 4
Eckhardt Sue Gail
Director
Transactions
- Award
Stock Option (right to buy)
2020-09-08+35,000→ 35,000 totalExercise: $8.94Exp: 2030-09-07→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.